TCG Crossover Management »

Inflarx Nv shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Inflarx Nv (IFRX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Inflarx Nv

Tip: Access up to 7 years of quarterly data

All positions including Inflarx Nv held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inflarx Nv by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $33M 15M 2.24

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Comm (ABVX)
Tango Therapeutics Comm (TNGX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Immunovant Comm (IMVT)
Spyre Therapeutics Comm (SYRE)
Dianthus Therapeutics Comm (DNTH)
Mirum Pharmaceuticals Comm (MIRM)
Zai Lab Ltd- Adrs (ZLAB)
Amylyx Pharmaceuticals Comm (AMLX)
Monte Rosa Therapeutics Comm (GLUE)
Biocryst Pharmaceuticals Comm (BCRX)
Vor Biopharma Comm (VOR)
Tyra Biosciences Comm (TYRA)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Inflarx Nv

Suvretta Capital Management
TCG Crossover Management
FMR
Commodore Capital
Spruce Street Capital
683 Capital Management
Farallon Capital Management
Stempoint Capital
Dr. Jeffrey R. Jay, M.D.
ADAR1 Capital Management
Kalehua Capital Management
Ameriprise Financial
Woodline Partners
Squadron Capital Management
Eversept Partners

View all funds holding Inflarx Nv